Affymetrix to Webcast Presentation at Piper Jaffray Health Care Conference
November 22 2006 - 9:00AM
Business Wire
Affymetrix, Inc. (Nasdaq:AFFX) today announced it will webcast its
presentation from the Piper Jaffray Health Care Conference in New
York City. Greg Schiffman, Executive Vice President and Chief
Financial Officer, will provide an overview of Affymetrix and
outline future growth opportunities at 3:00 p.m. ET on Wednesday,
November 29th. To access the live webcast or archived presentation,
please visit www.affymetrix.com and look for the "Investors" link
in the "Resources for" drop-down menu. An archived webcast will be
available for 30 days. About Affymetrix Affymetrix scientists
invented the world's first high-density microarray in 1989 and
began selling the first commercial microarray in 1994. Since then,
Affymetrix GeneChip(R) technology has become the industry standard
in molecular biology research. Affymetrix technology is used by the
world's top pharmaceutical, diagnostic and biotechnology companies
as well as leading academic, government and not-for-profit research
institutes. More than 1,400 systems have been installed around the
world and more than 7,000 peer-reviewed papers have been published
using the technology. Affymetrix' patented photolithographic
manufacturing process provides the most information capacity
available today on an array, enabling researchers to use a
whole-genome approach to analyzing the relationship between
genetics and health. Affymetrix is headquartered in Santa Clara,
Calif., with manufacturing facilities in Sacramento, Calif., and
Bedford, Mass. The company maintains important sales and marketing
operations in Europe and Asia and has about 1,100 employees
worldwide. For more information about Affymetrix, please visit the
company's website at www.affymetrix.com. NOTE: Affymetrix, the
Affymetrix logo, and GeneChip are registered trademarks owned or
used by Affymetrix Inc. Affymetrix, Inc. (Nasdaq:AFFX) today
announced it will webcast its presentation from the Piper Jaffray
Health Care Conference in New York City. Greg Schiffman, Executive
Vice President and Chief Financial Officer, will provide an
overview of Affymetrix and outline future growth opportunities at
3:00 p.m. ET on Wednesday, November 29th. To access the live
webcast or archived presentation, please visit www.affymetrix.com
and look for the "Investors" link in the "Resources for" drop-down
menu. An archived webcast will be available for 30 days. About
Affymetrix Affymetrix scientists invented the world's first
high-density microarray in 1989 and began selling the first
commercial microarray in 1994. Since then, Affymetrix GeneChip(R)
technology has become the industry standard in molecular biology
research. Affymetrix technology is used by the world's top
pharmaceutical, diagnostic and biotechnology companies as well as
leading academic, government and not-for-profit research
institutes. More than 1,400 systems have been installed around the
world and more than 7,000 peer-reviewed papers have been published
using the technology. Affymetrix' patented photolithographic
manufacturing process provides the most information capacity
available today on an array, enabling researchers to use a
whole-genome approach to analyzing the relationship between
genetics and health. Affymetrix is headquartered in Santa Clara,
Calif., with manufacturing facilities in Sacramento, Calif., and
Bedford, Mass. The company maintains important sales and marketing
operations in Europe and Asia and has about 1,100 employees
worldwide. For more information about Affymetrix, please visit the
company's website at www.affymetrix.com. NOTE: Affymetrix, the
Affymetrix logo, and GeneChip are registered trademarks owned or
used by Affymetrix Inc.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Sep 2023 to Sep 2024